Dr. Yong I. Cha, MD, PhD

Dr. Cha practices at Norton Brownsboro Hospital-Operating Room - HOPD in Louisville, Kentucky.

Dr. Cha's NPI, 1568635332, was assigned on April 11, 2008. Dr. Cha graduated from Vanderbilt University School Of Medicine in 2008. Dr. Cha holds Kentucky license 46430.

Dr. Cha's primary practice is Norton Brownsboro Hospital-Operating Room - HOPD, at 4960 Norton Healthcare Blvd, Louisville, KY 40241.

Dr. Cha's primary practice is Norton Brownsboro Hospital-Operating Room - HOPD in Louisville, Kentucky. Dr. Cha is also affiliated with Norton Hospital. The medical group on file is Norton Cancer Institute. Dmand AI also links Dr. Cha to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cha practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Cha's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Cha is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Cha's licenses on file in 4 states: Kentucky, California, Minnesota and Wisconsin.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, head & neck cancer radiation, lung cancer radiation, lymphoma radiation and pancreatic cancer radiation among the conditions Dr. Cha treats.

CMS data shows 2,177 Medicare services from Dr. Cha across 18 procedure codes in 2024, for 231 Medicare patients. Medicare paid $174,294 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 231 Medicare patients who saw Dr. Cha in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have cancer, and 75% have high blood pressure. 11% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cha's median patient age at 74, with 41% women.

In 2024, Dr. Cha wrote 66 Medicare Part D claims for 42 patients. 97% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $305 in total drug cost. In 2023, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Cha for performance year 2024, reported as part of a group. Dr. Cha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cha as offering telehealth.

Dmand AI links 7 papers to Dr. Cha, published from 2011 to 2013. Dr. Cha's most frequent co-authors are David Roy Gius, Michael F. Bassetti and Adam P. Dicker, MD.

Dmand AI links Dr. Cha to 2 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Urinary Bladder Neoplasms and Carcinoma, Bronchogenic. NRG Oncology sponsors the most, 2.

CMS Open Payments shows 15 general payments to Dr. Cha from 7 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 81% of the total. Brainlab, Inc. paid the most, $3,941.

Dr. Cha graduated from Vanderbilt University School Of Medicine in 2008.

Dr. Cha is in network with 18 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.